New hope for tough cancer: experimental drug joins forces with standard chemo
Disease control
Recruiting now
This study is testing whether adding a new oral drug called narmafotinib to a standard chemotherapy regimen (mFOLFIRINOX) is safe and effective for people with metastatic pancreatic cancer. The first part finds a safe dose, and the second part tests two doses in more people to pi…
Phase: PHASE1, PHASE2 • Sponsor: Amplia Therapeutics Limited • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC